Recently, researchers have used machine learning algorithms to investigate genomic alterations associated with metastatic prostate cancer (mCRPC), in the hope […]
Numerous datasets from historic clinical trials are being reviewed in the hope that existing drugs, that have already been cleared […]
The transformation currently underway within pharma organizations is undoubtedly driving the need for, and use of, real-world data and evidence. […]
We recently interviewed Anandbir Brar, Chief Executive Officer of Excelra. Excelra is the lead sponsor for our D4 Global virtual event. […]
Varenka Rodriguez DiBlasi, Exploratory Bioinformatics Lab Head of Cancer Immunology at Boehringer Ingelheim, shared a case study at D4 USA […]
D4 Europe is packed with case studies, evidence and intelligence that you can take back to your organisation and impact […]
Lung cancer is one of the leading causes of cancer death among men and women in the US. One option […]
The delta COVID-19 variant has contributed to a surge in the number of COVID cases across the globe, including a […]
Researchers have shown that relaxing the eligibility criteria of clinical trials in a data-driven manner can significantly increase the number […]
Proteolysis-targeting chimeras (PROTACs) are an emerging class of drugs that may offer new opportunities to overcome limitations associated with small-molecule […]
